These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 674296)

  • 21. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
    Kuca K; Cabal J
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial antagonism by cholinesterase reactivators of the effects of organophosphate compounds on shuttle-box avoidance.
    Rosić N
    Arch Int Pharmacodyn Ther; 1970 Jan; 183(1):139-47. PubMed ID: 5437315
    [No Abstract]   [Full Text] [Related]  

  • 23. Proceedings: Effects of pinacolyl-pyridinium derivatives on structure-bound acetylcholinesterase (E.C.3.1.1.7.) in vitro.
    Kuhnen H
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R52. PubMed ID: 4276593
    [No Abstract]   [Full Text] [Related]  

  • 24. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
    Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
    Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Equipotent cholinesterase reactivation in vitro by the nerve agent antidotes HI 6 dichloride and HI 6 dimethanesulfonate.
    Krummer S; Thiermann H; Worek F; Eyer P
    Arch Toxicol; 2002 Oct; 76(10):589-95. PubMed ID: 12373455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic efficacy of bis-pyridinium oximes against diisopropyl fluorophosphate (DFP) and soman intoxication in rodents.
    Dube SN; Kumar D; Sikder AK; Sikder N; Jaiswal DK; Das Gupta S
    Pharmazie; 1992 Jan; 47(1):68-9. PubMed ID: 1608992
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluorinated pyridinium oximes as potential reactivators for acetylcholinesterases inhibited by paraoxon organophosphorus agent.
    Jeong HC; Park NJ; Chae CH; Musilek K; Kassa J; Kuca K; Jung YS
    Bioorg Med Chem; 2009 Sep; 17(17):6213-7. PubMed ID: 19665386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type.
    Kapková P; Stiefl N; Sürig U; Engels B; Baumann K; Holzgrabe U
    Arch Pharm (Weinheim); 2003 Nov; 336(11):523-40. PubMed ID: 14639745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
    Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Opletalova V; Dolezal M
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3172-6. PubMed ID: 17383875
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective activity of pyridinium salts against soman poisoning in vivo and in vitro.
    Schoene K; Steinhanses J; Oldiges H
    Biochem Pharmacol; 1976 Sep; 25(17):1955-8. PubMed ID: 985533
    [No Abstract]   [Full Text] [Related]  

  • 31. New bispyridinium oximes: in vitro and in vivo evaluation of their biological efficiency in soman and tabun poisoning.
    Berend S; Vrdoljak AL; Radić B; Kuca K
    Chem Biol Interact; 2008 Sep; 175(1-3):413-6. PubMed ID: 18547553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of antidote protection against soman by pyridostigmine, HI-6 and acetylcholinesterase.
    Maxwell DM; Brecht KM; Doctor BP; Wolfe AD
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1085-9. PubMed ID: 8450452
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of monoquaternary pyridinium oximes potency to reactivate tabun-inhibited human acetylcholinesterase.
    Odzak R; Calić M; Hrenar T; Primozic I; Kovarik Z
    Toxicology; 2007 Apr; 233(1-3):85-96. PubMed ID: 16962227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
    Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
    J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-competitive inhibition of serum acetylcholinesterase (E.C.3.1.1.7) by vacor (N-3-pyridyl methyl-N'-P-nitrophenyl urea) in bandicoot rats.
    Devi SV; Krishnamoorthy RV
    Indian J Physiol Pharmacol; 1979; 23(4):285-90. PubMed ID: 528034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibition of acetylcholinesterase by 2-pyridinealdoxime methyl halide.
    Mounter LA; Ellin RI
    Mol Pharmacol; 1968 Sep; 4(5):452-6. PubMed ID: 5688122
    [No Abstract]   [Full Text] [Related]  

  • 37. Human platelet acetylcholinesterase: the effects of anticholinesterases on platelet function.
    Smith MJ; Braem B; Davis KD
    Thromb Haemost; 1980 Feb; 42(5):1615-9. PubMed ID: 7368161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aging-resistant organophosphate bioscavenger based on polyethylene glycol-conjugated F338A human acetylcholinesterase.
    Mazor O; Cohen O; Kronman C; Raveh L; Stein D; Ordentlich A; Shafferman A
    Mol Pharmacol; 2008 Sep; 74(3):755-63. PubMed ID: 18523134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and anticholinesterase activity of a novel series of 1-benzyl-4-((6-alkoxy-3-oxobenzofuran-2(3H)-ylidene) methyl) pyridinium derivatives.
    Nadri H; Pirali-Hamedani M; Shekarchi M; Abdollahi M; Sheibani V; Amanlou M; Shafiee A; Foroumadi A
    Bioorg Med Chem; 2010 Sep; 18(17):6360-6. PubMed ID: 20673725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quaternary salts of 4,3' and 4,4' bis-pyridinium monooximes: synthesis and biological activity.
    Chennamaneni SR; Vobalaboina V; Garlapati A
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3076-80. PubMed ID: 15908205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.